Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats

BACKGROUND: Surfactant therapy is a standard of care for preterm infants with respiratory distress and reduces the incidence of death and bronchopulmonary dysplasia in these patients. Our previous study found that mesenchymal stem cells (MSCs) attenuated hyperoxia-induced lung injury and the combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Hsiu-Chu, Chang, Chien-Hsiang, Chen, Chien-Han, Lin, Willie, Chen, Chung-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088571/
https://www.ncbi.nlm.nih.gov/pubmed/33933128
http://dx.doi.org/10.1186/s13287-021-02335-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088571/
https://www.ncbi.nlm.nih.gov/pubmed/33933128
http://dx.doi.org/10.1186/s13287-021-02335-4

Ejemplares similares